Literature DB >> 760748

Rate of onset of hypotensive effect of oral labetalol.

M J Serlin, M C Orme, M Maciver, G J Green, C M Macnee, A M Breckenridge.   

Abstract

1 Labetalol caused a fall in blood pressure within 2 h or oral doses of 100, 200 and 400 mg in six hypertensive patients. 2 This fall which was dose-related was maximal by 3 h and was sustained when the drug was given in doses of 100 mg 8 hourly, 200 mg 8 hourly and 400 mg 8 hourly. 3 This rapid fall in pressure when labetalol is given by mouth which contrasts to that seen on administration of pure beta-adrenoceptor blocking agents is a valuable therapeutic property.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 760748      PMCID: PMC1429443          DOI: 10.1111/j.1365-2125.1979.tb00916.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  9 in total

1.  Searching out low renin patients: limitations of some commonly used methods.

Authors:  J E Sealey; J H Laragh
Journal:  Am J Med       Date:  1973-09       Impact factor: 4.965

2.  Alpha and beta adrenergic blockade in hypertension.

Authors:  L J Beilin; B E Juel-Jensen
Journal:  Lancet       Date:  1972-05-06       Impact factor: 79.321

3.  Immediate hemodynamic effects of beta-adrenergic blockade with propranolol in normotensive and hypertensive man.

Authors:  M Ulrych; E D Frohlich; H P Dustan; I H Page
Journal:  Circulation       Date:  1968-03       Impact factor: 29.690

4.  Double-blind trial of labetalol.

Authors:  J Kane; I Gregg; D A Richards
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

5.  Labetalol in long-term treatment of hypertension.

Authors:  B N Prichard; A J Boakes
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

6.  Relationship between plasma concentrations and pharmacological effects of labetalol.

Authors:  D A Richards; J G Maconochie; R E Bland; R Hopkins; E P Woodings; L E Martin
Journal:  Eur J Clin Pharmacol       Date:  1977-01-03       Impact factor: 2.953

7.  Effect of blood pressure angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranolol.

Authors:  P M Trust; E A Rosei; J J Brown; R Fraser; A F Lever; J J Morton; J I Robertson
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

8.  Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors.

Authors:  J B Farmer; I Kennedy; G P Levy; R J Marshall
Journal:  Br J Pharmacol       Date:  1972-08       Impact factor: 8.739

9.  Treatment of hypertension with propranolol.

Authors:  B N Prichard; P M Gillam
Journal:  Br Med J       Date:  1969-01-04
  9 in total
  9 in total

Review 1.  The management of hypertension.

Authors:  B N Prichard; C W Owens
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

Review 2.  Comparison of labetalol with other anti-hypertensive drugs.

Authors:  B N Prichard; D A Richards
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

3.  The place of alpha-adrenoceptor and beta-adrenoceptor blockade in the treatment of hypertension.

Authors:  F Gross
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

4.  Acute management of severe hypertension with oral labetalol.

Authors:  R R Ghose
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

5.  Rapid reduction of blood pressure with acute oral labetalol.

Authors:  A B Davies; V Bala Subramanian; B Gould; E B Raftery
Journal:  Br J Clin Pharmacol       Date:  1982-05       Impact factor: 4.335

Review 6.  Drug treatment of hypertension.

Authors:  B N Prichard
Journal:  Drugs       Date:  1988       Impact factor: 9.546

7.  Labetalol in essential hypertension.

Authors:  A Breckenridge; M Orme; M J Serlin; M Maciver
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

Review 8.  Combined alpha- and beta-receptor inhibition in the treatment of hypertension.

Authors:  B N Prichard
Journal:  Drugs       Date:  1984       Impact factor: 9.546

9.  Towards precision critical care management of blood pressure in hemorrhagic stroke patients using dynamic linear models.

Authors:  Yuzhe Liu; Jody Manners; Yazan Bittar; Sherry H-Y Chou; Vanathi Gopalakrishnan
Journal:  PLoS One       Date:  2019-08-05       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.